Selective Use of Nonselective Beta-Blockers
JACC: Clinical Electrophysiology · 2026-07 · 12 (7) · 1745-1759
DOI: 10.1016/j.jacep.2026.05.002 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift JACC: Clinical Electrophysiology, 2026-07. Verfasst von Davide Genovese und 6 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Unit, Cardio-Neuro-Vascular Department, Ca' Foncello Hospital, Treviso, Italy. Electronic address: genovesedavide@outlook.com. Hauptthemen laut MEDLINE: Adrenergic beta-Antagonists, Anti-Arrhythmia Agents, Arrhythmias, Cardiac. Die Arbeit nennt 97 Literaturangaben.
Abstract (Originalsprache)
Beta-blockers (BBs) are a cornerstone of antiarrhythmic therapy, yet assuming a uniform "class effect" oversimplifies their diverse pharmacological properties and might compromise efficacy. This review synthesizes evidence comparing the antiarrhythmic effects of different BBs in various clinical settings. While cardioselective agents offer improved tolerability, they often fail to blunt the broad adrenergic surge driving specific arrhythmias. Nonselective BBs (eg, nadolol, propranolol) provide superior efficacy in inherited channelopathies, such as catecholaminergic polymorphic ventricular tachycardia and long QT syndrome, and life-threatening electrical storms. Furthermore, carvedilol is superior to metoprolol for preventing postoperative atrial fibrillation and reducing inappropriate shocks in patients with implantable cardioverter-defibrillators. Conversely, for managing chronic supraventricular tachycardia, cardioselective agents remain preferred. By leveraging distinct BB properties, clinicians can overcome the "one-size-fits-all" approach and tailor therapy to optimize antiarrhythmic efficacy. More research is needed to resolve uncertainties and assist clinicians in adopting a personalized approach to BBs therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiology Unit, Cardio-Neuro-Vascular Department, Ca' Foncello Hospital, Treviso, Italy. Electronic address: genovesedavide@outlook.com.
- Istituto di Ricovero e Cura a Carattere Scientifico Istituto Mediterraneo Trapianto e Terapia ad alta Specializzazione, UPMC Palermo, Palermo, Italy.
- Ospedale Pio XI, Desio, Italy.
- Arrhythmia Unit, Department of Cardiology, Careggi University Hospital, Florence, Italy.
- Cardiology Unit, Department of Clinical and Molecular Medicine, Sant'Andrea University Hospital, University Sapienza, Rome, Italy.
- Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.
Zitieren
APA
Genovese, D., Sgarito, G., Ruggiero, D., Perrotta, L., Francia, P., Santoro, F., & Mugnai, G. (2026). Selective Use of Nonselective Beta-Blockers. JACC: Clinical Electrophysiology, 12(7), 1745-1759. https://doi.org/10.1016/j.jacep.2026.05.002
Vancouver
Genovese D, Sgarito G, Ruggiero D, Perrotta L, Francia P, Santoro F, et al. Selective Use of Nonselective Beta-Blockers. JACC: Clinical Electrophysiology. 2026;12(7):1745-1759. doi:10.1016/j.jacep.2026.05.002
BibTeX
@article{Genovese2026,
author = {Genovese, Davide and Sgarito, Giuseppe and Ruggiero, Donatella and Perrotta, Laura and Francia, Pietro and Santoro, Francesco and Mugnai, Giacomo},
title = {Selective Use of Nonselective Beta-Blockers},
journal = {JACC: Clinical Electrophysiology},
year = {2026},
volume = {12},
number = {7},
pages = {1745--1759},
doi = {10.1016/j.jacep.2026.05.002}
}
EUVIMED